Search Reports
Categories
Categories

Global Erbb2 Antibody Market

Global Erbb2 Antibody Market Research Report 2025(Status and Outlook)

Report Code : PHA3165
Published Date : 17 July, 1905 | No of Pages: 147

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
The Erbb2 antibody, also known as HER2/neu antibody, is a monoclonal or polyclonal antibody designed to target the human epidermal growth factor receptor 2 (HER2), a protein encoded by the ERBB2 gene. Overexpression or amplification of HER2 is associated with aggressive forms of breast, gastric, and other cancers, making Erbb2 antibodies crucial for diagnostic, prognostic, and therapeutic applications. These antibodies are widely used in immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and enzyme-linked immunosorbent assays (ELISA) to detect HER2 expression levels in tumor tissues, guiding treatment decisions such as the use of HER2-targeted therapies like trastuzumab and pertuzumab. The market for Erbb2 antibodies is driven by the rising incidence of HER2-positive cancers, advancements in precision medicine, and increasing demand for companion diagnostics. Additionally, the expansion of biopharmaceutical research and development, along with growing investments in cancer biomarker discovery, further fuels market growth. However, challenges such as high costs of antibody development, stringent regulatory requirements, and the need for standardized testing protocols may impact market dynamics. Key players include leading biotechnology and pharmaceutical companies specializing in oncology diagnostics and therapeutics, with North America and Europe dominating the market due to well-established healthcare infrastructure and high adoption of targeted therapies. Emerging economies in Asia-Pacific are expected to witness significant growth due to improving healthcare access and increasing cancer awareness.

This report offers a comprehensive and in-depth analysis of the global Erbb2 Antibody market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Erbb2 Antibody market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Erbb2 Antibody market.
Global Erbb2 Antibody Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Santa Cruz Biotechnology
Thermo Fisher Scientific
Everest Biotech
Proteintech
Abbiotec
Bio X Cell
FineTest
Boster Bio
Merck
Hytest
Biorbyt
OriGene Technologies
ProSci

Market Segmentation (by Type)
Polyclonal
Monoclonal

Market Segmentation (by Application)
Enzyme Linked Immunosorbent Assay
Immunohistochemistry Frozen
Immunohistochemistry Paraffin
Immunoprecipitation
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Erbb2 Antibody Market
Overview of the regional outlook of the Erbb2 Antibody Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Erbb2 Antibody Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Erbb2 Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Erbb2 Antibody
      1.2 Key Market Segments
            1.2.1 Erbb2 Antibody Segment by Type
            1.2.2 Erbb2 Antibody Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Erbb2 Antibody Market Overview
      2.1 Global Market Overview
            2.1.1 Global Erbb2 Antibody Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Erbb2 Antibody Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Erbb2 Antibody Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Erbb2 Antibody Product Life Cycle
      3.3 Global Erbb2 Antibody Sales by Manufacturers (2020-2025)
      3.4 Global Erbb2 Antibody Revenue Market Share by Manufacturers (2020-2025)
      3.5 Erbb2 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Erbb2 Antibody Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Erbb2 Antibody Market Competitive Situation and Trends
            3.8.1 Erbb2 Antibody Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Erbb2 Antibody Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Erbb2 Antibody Industry Chain Analysis
      4.1 Erbb2 Antibody Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Erbb2 Antibody Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Erbb2 Antibody Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Erbb2 Antibody Market
      5.7 ESG Ratings of Leading Companies
  6 Erbb2 Antibody Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Erbb2 Antibody Sales Market Share by Type (2020-2025)
      6.3 Global Erbb2 Antibody Market Size Market Share by Type (2020-2025)
      6.4 Global Erbb2 Antibody Price by Type (2020-2025)
  7 Erbb2 Antibody Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Erbb2 Antibody Market Sales by Application (2020-2025)
      7.3 Global Erbb2 Antibody Market Size (M USD) by Application (2020-2025)
      7.4 Global Erbb2 Antibody Sales Growth Rate by Application (2020-2025)
  8 Erbb2 Antibody Market Sales by Region
      8.1 Global Erbb2 Antibody Sales by Region
            8.1.1 Global Erbb2 Antibody Sales by Region
            8.1.2 Global Erbb2 Antibody Sales Market Share by Region
      8.2 Global Erbb2 Antibody Market Size by Region
            8.2.1 Global Erbb2 Antibody Market Size by Region
            8.2.2 Global Erbb2 Antibody Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Erbb2 Antibody Sales by Country
            8.3.2 North America Erbb2 Antibody Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Erbb2 Antibody Sales by Country
            8.4.2 Europe Erbb2 Antibody Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Erbb2 Antibody Sales by Region
            8.5.2 Asia Pacific Erbb2 Antibody Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Erbb2 Antibody Sales by Country
            8.6.2 South America Erbb2 Antibody Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Erbb2 Antibody Sales by Region
            8.7.2 Middle East and Africa Erbb2 Antibody Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Erbb2 Antibody Market Production by Region
      9.1 Global Production of Erbb2 Antibody by Region(2020-2025)
      9.2 Global Erbb2 Antibody Revenue Market Share by Region (2020-2025)
      9.3 Global Erbb2 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Erbb2 Antibody Production
            9.4.1 North America Erbb2 Antibody Production Growth Rate (2020-2025)
            9.4.2 North America Erbb2 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Erbb2 Antibody Production
            9.5.1 Europe Erbb2 Antibody Production Growth Rate (2020-2025)
            9.5.2 Europe Erbb2 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Erbb2 Antibody Production (2020-2025)
            9.6.1 Japan Erbb2 Antibody Production Growth Rate (2020-2025)
            9.6.2 Japan Erbb2 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Erbb2 Antibody Production (2020-2025)
            9.7.1 China Erbb2 Antibody Production Growth Rate (2020-2025)
            9.7.2 China Erbb2 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Santa Cruz Biotechnology
            10.1.1 Santa Cruz Biotechnology Basic Information
            10.1.2 Santa Cruz Biotechnology Erbb2 Antibody Product Overview
            10.1.3 Santa Cruz Biotechnology Erbb2 Antibody Product Market Performance
            10.1.4 Santa Cruz Biotechnology Business Overview
            10.1.5 Santa Cruz Biotechnology SWOT Analysis
            10.1.6 Santa Cruz Biotechnology Recent Developments
      10.2 Thermo Fisher Scientific
            10.2.1 Thermo Fisher Scientific Basic Information
            10.2.2 Thermo Fisher Scientific Erbb2 Antibody Product Overview
            10.2.3 Thermo Fisher Scientific Erbb2 Antibody Product Market Performance
            10.2.4 Thermo Fisher Scientific Business Overview
            10.2.5 Thermo Fisher Scientific SWOT Analysis
            10.2.6 Thermo Fisher Scientific Recent Developments
      10.3 Everest Biotech
            10.3.1 Everest Biotech Basic Information
            10.3.2 Everest Biotech Erbb2 Antibody Product Overview
            10.3.3 Everest Biotech Erbb2 Antibody Product Market Performance
            10.3.4 Everest Biotech Business Overview
            10.3.5 Everest Biotech SWOT Analysis
            10.3.6 Everest Biotech Recent Developments
      10.4 Proteintech
            10.4.1 Proteintech Basic Information
            10.4.2 Proteintech Erbb2 Antibody Product Overview
            10.4.3 Proteintech Erbb2 Antibody Product Market Performance
            10.4.4 Proteintech Business Overview
            10.4.5 Proteintech Recent Developments
      10.5 Abbiotec
            10.5.1 Abbiotec Basic Information
            10.5.2 Abbiotec Erbb2 Antibody Product Overview
            10.5.3 Abbiotec Erbb2 Antibody Product Market Performance
            10.5.4 Abbiotec Business Overview
            10.5.5 Abbiotec Recent Developments
      10.6 Bio X Cell
            10.6.1 Bio X Cell Basic Information
            10.6.2 Bio X Cell Erbb2 Antibody Product Overview
            10.6.3 Bio X Cell Erbb2 Antibody Product Market Performance
            10.6.4 Bio X Cell Business Overview
            10.6.5 Bio X Cell Recent Developments
      10.7 FineTest
            10.7.1 FineTest Basic Information
            10.7.2 FineTest Erbb2 Antibody Product Overview
            10.7.3 FineTest Erbb2 Antibody Product Market Performance
            10.7.4 FineTest Business Overview
            10.7.5 FineTest Recent Developments
      10.8 Boster Bio
            10.8.1 Boster Bio Basic Information
            10.8.2 Boster Bio Erbb2 Antibody Product Overview
            10.8.3 Boster Bio Erbb2 Antibody Product Market Performance
            10.8.4 Boster Bio Business Overview
            10.8.5 Boster Bio Recent Developments
      10.9 Merck
            10.9.1 Merck Basic Information
            10.9.2 Merck Erbb2 Antibody Product Overview
            10.9.3 Merck Erbb2 Antibody Product Market Performance
            10.9.4 Merck Business Overview
            10.9.5 Merck Recent Developments
      10.10 Hytest
            10.10.1 Hytest Basic Information
            10.10.2 Hytest Erbb2 Antibody Product Overview
            10.10.3 Hytest Erbb2 Antibody Product Market Performance
            10.10.4 Hytest Business Overview
            10.10.5 Hytest Recent Developments
      10.11 Biorbyt
            10.11.1 Biorbyt Basic Information
            10.11.2 Biorbyt Erbb2 Antibody Product Overview
            10.11.3 Biorbyt Erbb2 Antibody Product Market Performance
            10.11.4 Biorbyt Business Overview
            10.11.5 Biorbyt Recent Developments
      10.12 OriGene Technologies
            10.12.1 OriGene Technologies Basic Information
            10.12.2 OriGene Technologies Erbb2 Antibody Product Overview
            10.12.3 OriGene Technologies Erbb2 Antibody Product Market Performance
            10.12.4 OriGene Technologies Business Overview
            10.12.5 OriGene Technologies Recent Developments
      10.13 ProSci
            10.13.1 ProSci Basic Information
            10.13.2 ProSci Erbb2 Antibody Product Overview
            10.13.3 ProSci Erbb2 Antibody Product Market Performance
            10.13.4 ProSci Business Overview
            10.13.5 ProSci Recent Developments
  11 Erbb2 Antibody Market Forecast by Region
      11.1 Global Erbb2 Antibody Market Size Forecast
      11.2 Global Erbb2 Antibody Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Erbb2 Antibody Market Size Forecast by Country
            11.2.3 Asia Pacific Erbb2 Antibody Market Size Forecast by Region
            11.2.4 South America Erbb2 Antibody Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Erbb2 Antibody by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Erbb2 Antibody Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Erbb2 Antibody by Type (2026-2033)
            12.1.2 Global Erbb2 Antibody Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Erbb2 Antibody by Type (2026-2033)
      12.2 Global Erbb2 Antibody Market Forecast by Application (2026-2033)
            12.2.1 Global Erbb2 Antibody Sales (K MT) Forecast by Application
            12.2.2 Global Erbb2 Antibody Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Santa Cruz Biotechnology
Thermo Fisher Scientific
Everest Biotech
Proteintech
Abbiotec
Bio X Cell
FineTest
Boster Bio
Merck
Hytest
Biorbyt
OriGene Technologies
ProSci
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400